Pediatric Radiology

, Volume 47, Issue 12, pp 1615–1621 | Cite as

Imaging of renal medullary carcinoma in children and young adults: a report from the Children’s Oncology Group

  • Jesse K. Sandberg
  • Elizabeth A. Mullen
  • Mariana M. Cajaiba
  • Ethan A. Smith
  • Sabah Servaes
  • Elizabeth J. Perlman
  • James I. Geller
  • Peter F. Ehrlich
  • Nicholas G. Cost
  • Jeffrey S. Dome
  • Conrad V. Fernandez
  • Geetika KhannaEmail author
Original Article



Renal medullary carcinoma is a rare renal malignancy of childhood. There are no large series describing the imaging appearance of renal medullary carcinoma in children.


To characterize the clinical and imaging features of pediatric renal medullary carcinoma at initial presentation.

Materials and methods

We retrospectively analyzed images of 25 pediatric patients with renal medullary carcinoma enrolled in the Children’s Oncology Group renal tumors classification, biology and banking study (AREN03B2) from March 2006 to August 2016. Imaging findings of the primary mass, and patterns of locoregional and distant spread were evaluated in correlation with pathological and surgical findings.


Median age at presentation was 13 years (range: 6-21 years), with a male predominance (3.2:1). The overall stage of disease at initial presentation was stage 1 in 1, stage 2 in 2 and stage 4 in 22. Maximum diameter of the primary renal mass ranged from 1.6 to 10.3 cm (mean: 6.6 cm) with a slight right side predilection (1.5:1). Enlarged (>1 cm short axis) retroperitoneal lymph nodes were identified at initial staging in 20/25 (80%) cases, 10 of which were histologically confirmed while the others did not undergo surgical sampling. Enlarged lymph nodes were also identified in the mediastinum (14/25; 56%) and supraclavicular regions (4/25; 16%). Metastatic disease was present in the lungs in 19/25 (76%) and liver in 6/25 (24%). The pattern of lung metastases was pulmonary lymphangitic carcinomatosis: 10 cases (9 bilateral, 1 unilateral), pulmonary nodules with indistinct margins: 6 cases, pulmonary nodules with distinct margins: 2 cases, while 1 case had pulmonary nodules with both indistinct and distinct margins. Pulmonary lymphangitic carcinomatosis was pathologically confirmed in 4/10 cases. All cases with pulmonary lymphangitic carcinomatosis had associated enlarged mediastinal lymph nodes.


Renal medullary carcinoma in children and young adults presents at an advanced local and distant stage in the majority of patients. The diagnosis of renal medullary carcinoma should be considered when a child or young adult presents with a poorly defined/infiltrative, centrally located renal mass, especially in the setting of known sickle cell hemoglobinopathy. Distant metastases are common at initial presentation in the lungs, distant lymph nodes and liver and often involve multiple sites simultaneously. Pulmonary lymphangitic carcinomatosis, a distinctive and uncommon form of lung metastasis in children, is common in this patient population.


Children Computed tomography Lymphangitic carcinomatosis Medullary carcinoma Renal tumor Sickle cell 


Compliance with ethical standards

Conflicts of interest



  1. 1.
    Davis CJ Jr, Mostofi FK, Sesterhenn IA (1995) Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 19:1–11CrossRefPubMedGoogle Scholar
  2. 2.
    Swartz MA, Karth J, Schneider DT et al (2002) Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology 60:1083–1089CrossRefPubMedGoogle Scholar
  3. 3.
    Dome JS, Fernandez CV, Mullen EA et al (2013) Children’s Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer 60:994–1000Google Scholar
  4. 4.
    Simpson L, He X, Pins M et al (2005) Renal medullary carcinoma and ABL gene amplification. J Urol 173:1883–1888CrossRefPubMedGoogle Scholar
  5. 5.
    Alvarez O, Rodriguez MM, Jordan L et al (2015) Renal medullary carcinoma and sickle cell trait: a systematic review. Pediatr Blood Cancer 62:1694–1699CrossRefPubMedGoogle Scholar
  6. 6.
    Blitman NM, Berkenblit RG, Rozenblit AM et al (2005) Renal medullary carcinoma: CT and MRI features. AJR Am J Roentgenol 185:268–272CrossRefPubMedGoogle Scholar
  7. 7.
    Shi Z, Zhuang Q, You R et al (2016) Clinical and computed tomography imaging features of renal medullary carcinoma: a report of six cases. Oncol Lett 11:261–266PubMedGoogle Scholar
  8. 8.
    Davidson AJ, Choyke PL, Hartman DS et al (1995) Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology 195:83–85CrossRefPubMedGoogle Scholar
  9. 9.
    Ng CS, Wood CG, Silverman PM et al (2008) Renal cell carcinoma: diagnosis, staging, and surveillance. AJR Am J Roentgenol 191:1220–1232CrossRefPubMedGoogle Scholar
  10. 10.
    Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual. Springer-Verlag, New YorkGoogle Scholar
  11. 11.
    Geller JI, Ehrlich PF, Cost NG et al (2015) Characterization of adolescent and pediatric renal cell carcinoma: a report from the Children's Oncology Group study AREN03B2. Cancer 121:2457–2464Google Scholar
  12. 12.
    Cajaiba MM, Khanna G, Smith EA et al (2016) Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations. Hum Pathol 48:81–87CrossRefPubMedGoogle Scholar
  13. 13.
    McCarville MB, Lederman HM, Santana VM et al (2006) Distinguishing benign from malignant pulmonary nodules with helical chest CT in children with malignant solid tumors. Radiology 239:514–520CrossRefPubMedGoogle Scholar
  14. 14.
    Prakash P, Kalra MK, Sharma A et al (2010) FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis. AJR Am J Roentgenol 194:231–236CrossRefPubMedGoogle Scholar
  15. 15.
    Rastogi R, Garg R, Thulkar S et al (2008) Unusual thoracic CT manifestations of osteosarcoma: review of 16 cases. Pediatr Radiol 38:551–558CrossRefPubMedGoogle Scholar
  16. 16.
    Ehrlich PF, Hamilton TE, Gow K et al (2016) Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group. Pediatr Blood Cancer 63:1905–1910Google Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Jesse K. Sandberg
    • 1
  • Elizabeth A. Mullen
    • 2
  • Mariana M. Cajaiba
    • 3
  • Ethan A. Smith
    • 4
  • Sabah Servaes
    • 5
  • Elizabeth J. Perlman
    • 3
  • James I. Geller
    • 6
  • Peter F. Ehrlich
    • 7
  • Nicholas G. Cost
    • 8
  • Jeffrey S. Dome
    • 9
  • Conrad V. Fernandez
    • 10
  • Geetika Khanna
    • 1
    Email author
  1. 1.Mallinckrodt Institute of RadiologyWashington University School of MedicineSt. LouisUSA
  2. 2.Department of Pediatric OncologyChildren’s Hospital Boston/Dana-Farber Cancer InstituteBostonUSA
  3. 3.Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children’s Hospital of ChicagoNorthwestern University Feinberg School of MedicineChicagoUSA
  4. 4.Section of Pediatric Radiology, C. S. Mott Children’s Hospital, Department of RadiologyUniversity of Michigan Health SystemAnn ArborUSA
  5. 5.Department of RadiologyChildren’s Hospital of PhiladelphiaPhiladelphiaUSA
  6. 6.Division of Pediatric Oncology, Cincinnati Children’s Hospital Medical CenterUniversity of CincinnatiCincinnatiUSA
  7. 7.Section of Pediatric Surgery, C. S. Mott Children’s Hospital, Department of SurgeryUniversity of Michigan Health SystemAnn ArborUSA
  8. 8.Division of Urology, Department of SurgeryUniversity of Colorado School of MedicineAuroraUSA
  9. 9.Division of Pediatric OncologyChildren’s National Medical CenterWashingtonUSA
  10. 10.Department of PediatricsDalhousie University & IWK Health CentreHalifaxCanada

Personalised recommendations